Genomic studies of uterine carcinosarcomas (UCS) have also revealed the presence of similar subtypes; however, the majority of tumors (~90%) contain TP53 mutations and a low tumor mutation burden (TMB) [7–9]. Here, TP53 is linked to neoplasm.